NC

Norcliffe Capital

Europe, East Sussex, United Kingdom, Wadhurst

Description

Norcliffe Capital provides tax-efficient investments in the life science and disruptive technology sectors.

Investor Profile

Norcliffe Capital has made 8 investments, with 3 in the past 12 months and 38% as lead.

Stage Focus

  • Seed (50%)
  • Series A (25%)
  • Series Unknown (25%)

Country Focus

  • United Kingdom (88%)
  • United States (13%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Health Diagnostics
  • Machine Learning
  • Biopharma
  • Manufacturing
  • Hospital
  • Medical Device
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Norcliffe Capital frequently co-invest with?

Eos
Europe, Fife, United Kingdom, Saint Andrews
Co-Investments: 3
Maven Capital Partners
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 1
SV
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 2
Mercia Fund Managers
Europe, Warwickshire, United Kingdom, Henley In Arden
Co-Investments: 1
Macmillan Cancer Support
Europe, England, United Kingdom, London
Co-Investments: 1
British Business Bank
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 1
University of Strathclyde
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 3
Scottish Enterprise
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 2
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 1
Oxford Science Enterprises
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 1

Which angels does Norcliffe Capital often collaborate with?

MB
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Norcliffe Capital?

Dxcover

Glasgow, Glasgow City, United Kingdom

Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.

BiotechnologyHealth CareHealth DiagnosticsMachine LearningMedical
Series UnknownFeb 3, 2025
Amount Raised: $6,200,000
Oxford Endovascular

Oxford, Oxfordshire, United Kingdom

Oxford Endovascular are developing a novel treatment for treating brain aneurysms.

BiotechnologyHealth CareMedical
Series AMay 20, 2024
Amount Raised: $10,167,678
Glen Clova Scientific

Scotland, Indiana, United States

Glen Clova Scientific is a company that developing a new gneration of active biological drugs.

BiopharmaBiotechnologyHospital
SeedApr 24, 2024
Amount Raised: $4,983,691
SMi Systems

Newmarket, Flintshire, United Kingdom

SMi Systems is a biomedical research and medical equipment manufacturing organization.

BiopharmaManufacturingMedical
SeedJun 15, 2023
Amount Raised: $7,600,000
Dxcover

Glasgow, Glasgow City, United Kingdom

Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.

BiotechnologyHealth CareHealth DiagnosticsMachine LearningMedical
Series AFeb 1, 2023
Amount Raised: $9,290,745
Aureum Diagnostics

Glasgow, Glasgow City, United Kingdom

Aureum Diagnostics is a point of care diagnostics platform and medical equipment manufacturing organization.

ManufacturingMedicalMedical Device
SeedJan 1, 2023
Biosceptre

Babraham, Cambridgeshire, United Kingdom

Biosceptre has identified a cancer target, nf-P2X7, present in many cancer types, and importantly not found in healthy tissue.

BiotechnologyLife SciencePharmaceutical
Series UnknownMar 9, 2021
Amount Raised: $9,600,000
Dxcover

Glasgow, Glasgow City, United Kingdom

Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers.

BiotechnologyHealth CareHealth DiagnosticsMachine LearningMedical
SeedMar 4, 2021
Amount Raised: $1,528,302